IoM Drug Safety Meeting Will Hear Remarks By House Anti-Narcotics Staffer
This article was originally published in The Pink Sheet Daily
Executive Summary
The Institute of Medicine’s second meeting on the U.S. drug safety system will also include presentations from FDA, CMS and AHRQ on their role in drug safety. Other scheduled speakers include a series of consumer representatives.